Logo image of MREO

MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Analyst Earnings Estimates

NASDAQ:MREO - Nasdaq - US5894921072 - ADR - Currency: USD

2.85  -0.02 (-0.7%)

After market: 2.85 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MREO revenue by date.MREO revenue by date.
36.46M
-100.00%		10M
-100.00%		21.757M36.788M
69.09%		77.166M
109.76%		221.72M
187.33%		351.12M
58.36%		472.61M
34.60%		631.63M
33.65%		784.02M
24.13%
EBITDA
YoY % growth
MREO ebitda by date.MREO ebitda by date.
-20.3M
43.56%		-42.84M
-111.03%		-27.569M
35.65%		-42.024M
-52.43%		-20.4M
51.46%		-18.666M
8.50%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MREO ebit by date.MREO ebit by date.
-20.94M
44.26%		-43.57M
-108.07%		-28.416M
34.78%		-36.025M
-26.78%		-31.98M
11.23%		-27.885M
12.80%		-9.09M
67.40%		99.667M
1,196.50%		198.44M
99.10%		300.18M
51.27%		432.18M
43.97%		555.42M
28.52%
Operating Margin
MREO operating margin by date.MREO operating margin by date.
-57.43%N/A-284.16%N/A-146.99%-75.80%-11.78%44.95%56.52%63.52%68.42%70.84%
EPS
YoY % growth
MREO eps by date.MREO eps by date.
N/A
91.67%		N/A
-69.23%		N/A
42.05%		-0.05
-11.87%		-0.17
-248.47%		-0.03
84.29%		-0.02
41.21%		0.11
790.85%		0.20
87.80%		0.28
38.09%		0.41
45.42%		0.50
22.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.01
-4,638.16%		0.010.00
102.64%		-0.17
-116.42%		-0.01
7.60%
Revenue
Q2Q % growth
-100.00%		17.754M7.464M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.653M
69.55%		13.568M
237.05%		616.009K
104.81%		-8.893M
5.12%		-9.686M
-11.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.08 -0.01-0.06-449.62%
Q2 2024
Q2Q % growth		 -0.08
-38,748.04%		-0.01-0.07-886.64%
MREO Yearly EPS VS EstimatesMREO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
-100.00%		%
Q4 2023
Q2Q % growth		 10M 37.23M-27.23M-73.14%
MREO Yearly Revenue VS EstimatesMREO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-185.84% -132.2% -87.94% -121.21%
Revenue-100% -100% -100% -100%